Acrivon Therapeutics, Inc. · NASDAQ:ACRV

Ra Capital Management, L.P. reported a 21.60% stake in Acrivon Therapeutics, Inc. (Schedule 13D/A)

Event Mar 19, 2026 · Filed Mar 23, 2026

Ra Capital Management, L.P. reported a 21.60% stake in Acrivon Therapeutics, Inc., 8,396,018 shares, with active intent on Mar 19, 2026. Filed Mar 23, 2026 (Schedule 13D/A).

Stake
21.60%
Shares
8,396,018
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.21.60%8,396,018
Peter Kolchinsky21.60%8,396,018
Rajeev Shah21.60%8,396,018
RA Capital Healthcare Fund, L.P.20.40%7,914,206

Source

View original at SEC

Related